AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

While patients with Parkinson’s initially start taking oral drugs like levodopa and carbidopa ... patients who cannot have apomorphine, with a list price of £84.70 per vial ahead of discounts.

Biogen Inc. (NASDAQ: BIIB) has steadily declined since peaking at $468.55 in 2021, as shares are trading down 70.64% from ...

“Any obesity is a big risk for high blood pressure but, again, abdominal fat is an especially big contributor,” says Chiesa. ...

We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...

The following is a look at some of those who make up what is becoming an alarmingly long list of performers who are dealing with health issues: Iconic singer Michael Bolton’s recent announcement as he ...

In the second episode of The Deep End, listeners hear what it’s like to live with severe depression and the backstory of an experimental treatment.

Kane Biotech Inc. (the "Company", "Kane" or "Kane Biotech") announces that today it has completed the second and final closing of its previously announced non-brokered private placement offering (the ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental More than 60 years ago, Bill Medley, now 84, ...